{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:56:06Z","timestamp":1791842166954,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Science and Technology Support Program of Sichuan Province","doi-asserted-by":"crossref","award":["2022NSFSC1494"],"award-info":[{"award-number":["2022NSFSC1494"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82120108015"],"award-info":[{"award-number":["82120108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371925"],"award-info":[{"award-number":["82371925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1\u20133\u20135 project for disciplines of excellence of West China Hospital","award":["ZYGD23019"],"award-info":[{"award-number":["ZYGD23019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure with reduced ejection fraction (HFrEF) is associated with a high rate of mortality and morbidity. Evidence has shown that sex differences may be an important contributor to phenotypic heterogeneity in patients with HFrEF. Although diabetes mellitus (DM) frequently coexists with HFrEF and results in a worse prognosis, there remains a need to identify sex-related differences in the characteristics and outcomes of this population. In this study, we aimed to investigate the between-sex differences in clinical profile, left ventricular (LV) remodeling, and cardiovascular risk factors and outcomes in patients with HFrEF concomitant with DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 273 patients with HFrEF concomitant with DM who underwent cardiac MRI were included in this study. Clinical characteristics, LV remodeling as assessed by cardiac MRI, and cardiovascular risk factors and outcomes were compared between sexes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women were older, leaner and prone to have anemia and hypoproteinemia but less likely to have ischemic etiology. Cardiac MRI revealed that despite similar LVEFs between the sexes, there was more LV concentric remodeling, less impaired global systolic peak strain in longitudinal and circumferential components and a decreased likelihood of late gadolinium enhancement presence in women than in men. During a median follow-up time of 34.6\u00a0months, women exhibited better overall survival than men did (log-rank P\u2009=\u20090.042). Multivariable Cox proportional hazards analysis indicated different risk factors for predicting outcomes between sexes, with hypertension [hazard ratio (HR)\u2009=\u20092.05, 95% confidence interval (CI) 1.05 to 4.85, P\u2009=\u20090.041] and hypoproteinemia (HR\u2009=\u20092.27, 95% CI 1.06 to 4.37, P\u2009=\u20090.039) serving as independent determinants of outcomes in women, whereas ischemic etiology (HR\u2009=\u20091.96, 95% CI 1.11 to 3.48, P\u2009=\u20090.021) and atrial fibrillation (HR\u2009=\u20091.86, 95% CI 1.02 to 3.41, P\u2009=\u20090.044) served as independent determinants of outcomes in men.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among patients with HFrEF concomitant with DM, women displayed different LV remodeling and risk factors and had better survival than men did. Sex-based phenotypic heterogeneity in patients with HFrEF in the context of DM should be addressed in clinical practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-024-02362-4","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T14:02:24Z","timestamp":1721656944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sex differences in clinical profile, left ventricular remodeling and cardiovascular outcomes among diabetic patients with heart failure and reduced ejection fraction: a cardiac-MRI-based study"],"prefix":"10.1186","volume":"23","author":[{"given":"Ke","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"issue":"5","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","volume":"324","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488\u2013504.","journal-title":"JAMA"},{"issue":"6","key":"2362_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368\u201378.","journal-title":"Nat Rev Cardiol"},{"issue":"47","key":"2362_CR3","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859\u20133868c.","journal-title":"Eur Heart J"},{"issue":"17","key":"2362_CR4","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","volume":"137","author":"A Pandey","year":"2018","unstructured":"Pandey A, Omar W, Ayers C, et al. Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation. 2018;137(17):1814\u201323.","journal-title":"Circulation"},{"issue":"1","key":"2362_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacc.2018.09.081","volume":"73","author":"P Dewan","year":"2019","unstructured":"Dewan P, R\u00f8rth R, Jhund PS, et al. Differential impact of heart failure with reduced ejection fraction on men and women. J Am Coll Cardiol. 2019;73(1):29\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2362_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ejhf.1996","volume":"23","author":"CJ Taylor","year":"2021","unstructured":"Taylor CJ, Ord\u00f3\u00f1ez-Mena JM, Jones NR, et al. National trends in heart failure mortality in men and women, United Kingdom, 2000\u20132017. Eur J Heart Fail. 2021;23(1):3\u201312.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2362_CR7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jchf.2023.07.029","volume":"11","author":"M Pabon","year":"2023","unstructured":"Pabon M, Cunningham J, Claggett B, et al. Sex differences in heart failure with reduced ejection fraction in the GALACTIC-HF trial. JACC Heart Fail. 2023;11(12):1729\u201338.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2362_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCRESAHA.121.319900","volume":"130","author":"EM DeFilippis","year":"2022","unstructured":"DeFilippis EM, Beale A, Martyn T, et al. Heart failure subtypes and cardiomyopathies in women. Circ Res. 2022;130(4):436\u201354.","journal-title":"Circ Res"},{"issue":"3","key":"2362_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jchf.2019.11.005","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Voors AA, Sharma A, et al. Distinct pathological pathways in patients with heart failure and diabetes. JACC Heart Fail. 2020;8(3):234\u201342.","journal-title":"JACC Heart Fail"},{"issue":"39","key":"2362_CR10","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"issue":"1","key":"2362_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2017.07.012","volume":"6","author":"WJ Paulus","year":"2018","unstructured":"Paulus WJ, Dal Canto E. Distinct myocardial targets for diabetes therapy in heart failure with preserved or reduced ejection fraction. JACC Heart Fail. 2018;6(1):1\u20137.","journal-title":"JACC Heart Fail"},{"issue":"36","key":"2362_CR12","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"1","key":"2362_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-023-01745-3","volume":"22","author":"WL Qian","year":"2023","unstructured":"Qian WL, Xu R, Shi R, et al. The worsening effect of anemia on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T CMR feature tracking study. Cardiovasc Diabetol. 2023;22(1):15.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jchf.2016.09.015","volume":"5","author":"IEM Bank","year":"2017","unstructured":"Bank IEM, Gijsberts CM, Teng TK, et al. Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure. JACC Heart Fail. 2017;5(1):14\u201324.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2362_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-022-01656-9","volume":"21","author":"KB Won","year":"2022","unstructured":"Won KB, Lee BK, Lin FY, et al. Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry. Cardiovasc Diabetol. 2022;21(1):239.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2362_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ejhf.2154","volume":"23","author":"A Ravera","year":"2021","unstructured":"Ravera A, Santema BT, Sama IE, et al. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City cardiomyopathy questionnaire and the EuroQol 5 dimensions questionnaire. Eur J Heart Fail. 2021;23(4):567\u201377.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"2362_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013114","volume":"8","author":"J Yap","year":"2019","unstructured":"Yap J, Tay WT, Teng TK, et al. Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. J Am Heart Assoc. 2019;8(17): e013114.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2362_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2362_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ejhf.1358","volume":"21","author":"C Chandramouli","year":"2019","unstructured":"Chandramouli C, Teng TK, Tay WT, et al. Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry. Eur J Heart Fail. 2019;21(3):297\u2013307.","journal-title":"Eur J Heart Fail"},{"key":"2362_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02430-5","author":"L Grassow","year":"2024","unstructured":"Grassow L, Gr\u00f6schel J, Saad H, et al. Sex-specific structural and functional cardiac remodeling during healthy aging assessed by cardiovascular magnetic resonance. Clin Res Cardiol. 2024. https:\/\/doi.org\/10.1007\/s00392-024-02430-5.","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2362_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12933-021-01407-2","volume":"20","author":"Y Gao","year":"2021","unstructured":"Gao Y, Xu HY, Guo YK, et al. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance. Cardiovasc Diabetol. 2021;20(1):215.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2362_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008997","volume":"15","author":"R Rosenzweig","year":"2022","unstructured":"Rosenzweig R, Kumar V, Gupta S, et al. Estrogen receptor-\u03b2 agonists modulate t-lymphocyte activation and ameliorate left ventricular remodeling during chronic heart failure. Circ Heart Fail. 2022;15(7): e008997.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"2362_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","volume":"5","author":"U Sartipy","year":"2017","unstructured":"Sartipy U, Dahlstr\u00f6m U, Fu M, Lund LH. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 2017;5(8):565\u201374.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2362_CR24","first-page":"446","volume":"21","author":"VT Truong","year":"2020","unstructured":"Truong VT, Palmer C, Wolking S, et al. Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers. Eur Heart J Cardiovasc Imaging. 2020;21(4):446\u201353.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"2362_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/ejhf.645","volume":"18","author":"F Triposkiadis","year":"2016","unstructured":"Triposkiadis F, Pieske B, Butler J, et al. Global left atrial failure in heart failure. Eur J Heart Fail. 2016;18(11):1307\u201320.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"2362_CR26","first-page":"HAE000000000000","volume":"14","author":"R Gopinathannair","year":"2021","unstructured":"Gopinathannair R, Chen LY, Chung MK, et al. Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American heart association. Circ Arrhythm Electrophysiol. 2021;14(6):HAE0000000000000078.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2362_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12933-023-02014-z","volume":"22","author":"K Nabrdalik","year":"2023","unstructured":"Nabrdalik K, Kwiendacz H, Irlik K, et al. Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project. Cardiovasc Diabetol. 2023;22(1):318.","journal-title":"Cardiovasc Diabetol"},{"key":"2362_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijcard.2017.11.019","volume":"252","author":"Y Honda","year":"2018","unstructured":"Honda Y, Watanabe T, Otaki Y, et al. Gender differences in the impact of anemia on subclinical myocardial damage and cardiovascular mortality in the general population: The Yamagata (Takahata) study. Int J Cardiol. 2018;252:207\u201312.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2362_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","volume":"22","author":"Y An","year":"2023","unstructured":"An Y, Xu BT, Wan SR, et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023;22(1):237.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2362_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC Heart Fail. 2017;5(8):543\u201351.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2362_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ejhf.2809","volume":"25","author":"KY Feng","year":"2023","unstructured":"Feng KY, Ambrosy AP, Zhou Z, et al. Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial. Eur J Heart Fail. 2023;25(4):553\u201361.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2362_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurjhf\/hfr154","volume":"14","author":"M Liu","year":"2012","unstructured":"Liu M, Chan CP, Yan BP, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14(1):39\u201344.","journal-title":"Eur J Heart Fail"},{"key":"2362_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","volume":"102","author":"AA Manolis","year":"2022","unstructured":"Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Low serum albumin: a neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022;102:24\u201339.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2362_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-023-01824-5","volume":"22","author":"P Hrabalova","year":"2023","unstructured":"Hrabalova P, Bohuslavova R, Matejkova K, et al. Dysregulation of hypoxia-inducible factor 1\u03b1 in the sympathetic nervous system accelerates diabetic cardiomyopathy. Cardiovasc Diabetol. 2023;22(1):88.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02362-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T14:05:18Z","timestamp":1721657118000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02362-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02362-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Research Ethics Committees of West China Hospital and was complied with the Declaration of Helsinki. Written informed consent was waived because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}